Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$912K Buy
4,100
+2,400
+141% +$436K ﹤0.01% 1740
2026
Q1
$261K Buy
1,700
+200
+13% +$27.1K ﹤0.01% 2200
2025
Q4
$170K Sell
1,500
-23,500
-94% -$2.86M ﹤0.01% 2423
2025
Q3
$3.32M Sell
25,000
-25,300
-50% -$3.47M ﹤0.01% 1230
2025
Q2
$7.17M Sell
50,300
-44,900
-47% -$6.36M 0.01% 782
2025
Q1
$14.6M Buy
95,200
+92,300
+3,183% +$14.5M 0.03% 442
2024
Q4
$434K Buy
+2,900
New +$455K ﹤0.01% 2223

Other funds holding DVA

PEAK6's DVA Position: Q2 2026 in Review

PEAK6 reduced its DaVita (DVA) stake by 97% in Q2 2026, selling an estimated $3.04M and leaving 582 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

PEAK6 first reported a position in DVA in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.66M in Q1 2026. 631 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • PEAK6 held 582 shares of DaVita worth $129K as of Q2 2026.
  • PEAK6 sold 16,750 DaVita shares in Q2 2026, an estimated $3.04M.
  • DaVita made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2364 holding.
  • PEAK6 first reported a position in DaVita in Q4 2024 and has held it in 7 quarters since.
  • PEAK6's DaVita position peaked at $2.66M in Q1 2026.
  • 631 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.